Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Accured Expenses (2019 - 2025)

Nutex Health's Change in Accured Expenses history spans 6 years, with the latest figure at -$923000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 78.13% year-over-year to -$923000.0; the TTM value through Dec 2025 reached $1.6 million, down 87.15%, while the annual FY2025 figure was $1.6 million, 87.15% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$923000.0 at Nutex Health, down from $347000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $9.4 million in Q2 2022 and bottomed at -$6.9 million in Q3 2022.
  • The 5-year median for Change in Accured Expenses is $1.9 million (2023), against an average of $1.2 million.
  • The largest annual shift saw Change in Accured Expenses tumbled 703.66% in 2022 before it skyrocketed 1269.8% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.8 million in 2021, then plummeted by 246.02% to -$4.0 million in 2022, then skyrocketed by 58.42% to -$1.7 million in 2023, then tumbled by 152.2% to -$4.2 million in 2024, then surged by 78.13% to -$923000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Change in Accured Expenses are -$923000.0 (Q4 2025), $347000.0 (Q3 2025), and $2.9 million (Q2 2025).